Federica Marmorino

7PUBLICATIONS
77CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMedical biochemistry - amino acids and metabolitesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 08, 2026
Upfront Modified FOLFOXIRI Plus Panitumumab for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Results of the Phase III TRIPLETE Study.

Veronica Conca, Daniele Rossini, Carlotta Antoniotti

|Sep 10, 2025
Germline Findings From Tumor-Only Comprehensive Genomic Profiling in the RATIONAL Study: A Missed Opportunity?

Riziero Esposito Abate, Alessandro Morabito, Michele Milella

|Aug 14, 2024
Acyl-CoA binding protein for the experimental treatment of anorexia.

Hui Chen, Stéphanie Moriceau, Adrien Joseph

|Jun 12, 2024
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study.

Carlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio

|Aug 14, 2023
The prognostic value of radiomic features in liver-limited metastatic colorectal cancer patients from the TRIBE2 study.

Federica Marmorino, Lorenzo Faggioni, Daniele Rossini

|Nov 10, 2022
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases.

Federica Marmorino, Michele Prisciandaro, Mirella Giordano

Pageof 2